Werewolf Therapeutics, Ambros Therapeutics announce merger and $150 million placement
Werewolf Therapeutics and Ambros Therapeutics announce a merger agreement and a concurrent oversubscribed $150 million private placement.
Top Small Cap Positive News Movers Premarket: RFAI: +445% Momentum Mover HOWL: +75% Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 million Private Placement JUNS: +55% Momentum Mover SUGP: +51% REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT GOSS: +47% Announces Up to $250 Million Structured Private Placement, Including $150 Million of Committed Capital, to Fund Seralutinib Through Potential FDA Approval JXG: +36% Momentum Mover ADXN: +27% Momentum Mover BIVI: +19% Momentum Mover